Granulomatous lung disease in lymphoma patient after rituximab treatment

P. Janowiak (Gdansk, Poland)

Source: Virtual Congress 2020 – Interstitial lung diseases
Session: Interstitial lung diseases
Session type: Challenging clinical cases
Number: 3837
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Janowiak (Gdansk, Poland). Granulomatous lung disease in lymphoma patient after rituximab treatment. Virtual Congress 2020 – Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Interstitial lung disease and fever as main manifestations of angiotropic lymphoma
Source: Eur Respir J 2001; 18: Suppl. 33, 528s
Year: 2001

Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014

Endobronchial primary pulmonary non-Hodgkin lymphoma development in a patient with rheumatoid arthritis
Source: Eur Respir J 2001; 18: Suppl. 33, 398s
Year: 2001

Rituximab for the treatment of chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015

Rituximab therapy for interstitial lung disease in patients with antisynthetase syndrome
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Rituximab therapy in a patient with steroid-refractory bird fancier's lung
Source: International Congress 2019 – CCC Interstitial lung diseases
Year: 2019

Rituximab-induced lung disease: a systematic literature review
Source: Eur Respir J 2010; 35: 681-687
Year: 2010

Primary pulmonary non-Hodgkin's lymphoma [NHL] and advanced NHL with pulmonary involvement -rare entity and difficult diagnosis
Source: Eur Respir J 2002; 20: Suppl. 38, 467s
Year: 2002

Clinical and radiological correlation of pulmonary complications in CHOP versus rituximab-CHOP regimen treated non-Hodgkin’s lymphoma in Thailand
Source: International Congress 2017 – Rare diseases
Year: 2017

Treatment of relapsed hydatid disease of lungs.
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020

Pulmonary toxicity of treatments for leukaemia and lymphoma
Source: International Congress 2018 – Respiratory medicine meets hematology
Year: 2018

Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease
Source: International Congress 2017 – Novel and old entities
Year: 2017

Pulmonary non-Hodgkin‘s lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015

Pulmonary tuberculosis in hodgkin's disease after high dose chemotherapy
Source: Annual Congress 2003 - Clinical aspects of tuberculosis
Year: 2003

Primary pulmonary lymphoma
Source: Eur Respir J 2002; 20: 750-762
Year: 2002

Efficacy of switching from cyclosporine A to tacrolimus in patients with refractory CTD-ILD
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017